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Summary.-Two hundred and fifty cases of histologically proven Hodgkin's disease
have been reviewed. These cases were classified according to the Rye Conference
histological classification (Lukes et al., 1966a) and accordingtotheCrossclassification
(Cross, 1969). Overall, both classifications were reasonably effective in predicting
prognosis but that of Cross with its seven sub-groups proved more difficult to use
than the simpler Rye classification. In all cases the follow-up period exceeded
5 years. A study was made of the influence of clinical symptoms on survival with
particular reference to night sweats, fever, pruritus, anorexia, lassitude, weight
loss, haematological abnormalities and splenic enlargement. The presence of these
abnormalities adversely affected prognosis. The spread of the disease from one
group of nodes to the next was also documented. Considering all cases the 5-year
survival was 54%. The 5-year survivals according to histological type were:
lymphocytic predominance 69%, nodular sclerosis 57%, mixed cellularity 41%,
lymphocytic depletion 40%. The 10-year survival was 23% which, when corrected
by the actuarial method (Berkson and Gage, 1950), rose to 36%. The importance of
symptomatology as well as histological grading in the prognosis of Hodgkin's
disease is confirmed.
IN 1957 a review of 602 cases of
primary tumours of lymphoid tissue was
presented from Westminster Hospital
(Lumb and Newton, 1957). In recent
years there have been a number of
advances in the classification and treat-
-ment ofcertain lymphomata. The present
communication deals exclusively with
cases of Hodgkin's disease and these have
been considered from the points of view
of histology and clinical findings in
relation to prognosis.
PART I-PATHOLOGY
Adequate histological sections were
available in all the 250 cases presented
here and these were reviewed by one of
us (D.H.M.) without knowledge of the
clinical histories. On histological grounds
they were classified according to the
Rye Conference histological classification
(Lukes et al., 1966a) and according to the
Cross classification (Cross, 1969). Only
the Rye classification will be used in this
communication. The classification of
Cross will form the subject of a separate
communication. In an appreciable num-
ber of cases the poor quality of the
sections prevented classification and these
have been excluded from the present
study.
First, certain general points need
emphasis. While the majority of cases
in any series will fall fairly readily into
one of the sub-divisions, borderline and
debatable cases are unavoidable. The
degree to which experienced pathologists
may differ has been clearly demonstrated
recently (Keller et al., 1968). Secondly,
slides which may be described as adequate
rather than excellent may contain enoughHODGKIN'S DISEASE
distortion to render the identification of
lacuna cells difficult. The Cross class-
fication with its greater emphasis on
cytological detail in the assessment of
differentiation is particularly dependent
on excellent preparations. Lastly the
tendency of surgeons to remove small
and easily accessible nodes from an
affected group may present a pathologist
with material unrepresentative of the
disease as a whole.
The older classifications of Hodgkin's
disease regardless of terminology suffered
from one great defect. The recognition
of a relatively benign form and a par-
ticularly aggressive one still left over
80% in a single group with a very wide
spectrum of survival time. Recent classi-
fications (Lukes et al., 1966a; Lukes,
Butler and Hicks, 1966b; Cross, 1969)
have endeavoured to split this 80%
into sub-groups in which a histological
picture is more closely related to prog-
nosis. An ideal classification would be
intelligible to and useable by pathologists
who do not claim to have made a special
study of lymph nodes. It should also
give a reasonable guide to prognosis.
The classification of Lukes and his
co-workers (1966a; 1966b) is well known
and will not be described here. The
so-called Rye classification (Lukes et al.,
1966a) is a simplified form of the original
one and divides Hodgkin's disease into
four separate histological types: 1. lympho-
cytic predominance; 2. nodular sclerosis;
3. mixed cellularity, and 4. lymphocytic
depletion. The term lymphocytic pre-
dominance is used to include the lympho-
cytic and/or histiocytic types both nodular
and diffuse, of the original Lukes classi-
fication. The term lymphocytic depletion
includes the diffuse fibrosis and reticular
types of the same classification.
A comment about nodular sclerosing
Hodgkin's disease is necessary. The
incidence of this particular type has
varied widely from series to series, e.g.
Kadin, Glatstein and Dorfman (1971)
73%, Keller et al. (1968) 52%, Franssila,
Kalima and Voutilainen (1967) 470o,
6§
Lukes et al. (1966b) 40%, Cross (1968)
16%. This is due in part to a certain
vagueness of definition, particularly in
respect ofthe amount ofcollagennecessary
to justify the diagnosis and whether the
presence of the lacuna form of Reed-
Sternberg cell is an absolute prerequisite.
In addition some workers (Kadin et al.,
1971; Strum and Rappaport, 1971) accept
the concept of a cellular phase of nodular
sclerosis where lacuna cells are present
without any collagen. In the present
series we have included under nodular
sclerosis those nodes where islands of
Hodgkin tissue were quite clearly de-
marcated by broad bands of collagen.
Lacuna cells were present in the great
majority of cases. In a very few instances
they were not identified with certainty but
these cases have been included if the
fibrotic element was characteristic.
The distribution of the 250 cases in
the present series between the sub-groups
is shown in Table I.
TABLE I.-Rye Classification.
Distribution of Histological Types
Franssila Keller Present Lukes
et al. et al. series et al.
Lymphocytic
predominance 9% . 5% . 29% . 16%
Nodular sclerosis 47% 52% . 31% . 40%
Mixed cellularity 33% . 37% . 24% . 26%
Lymphocytic
depletion 110% 6% . 16% . 18%
They are compared with the figures found
in other series (Franssila et al., 1967;
Keller et al., 1968). The figures obtained
by Lukes et al. (1966b) are also shown
translated into the Rye terminology.
Relation of survival to histological type
All 250 cases were followed for at least
5 years. Fig. 1-3 show the percentage
survivals for all cases; for cases where
there was no record in the notes of night
sweats, pruritus or fever, and for cases
with no systemic symptoms and only one
group of nodes involved on presentation.
After 5 years the number available for
study slowly declined, but the 10-year
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survival figure for all cases was 23 0
which, when corrected by the actuarial
method, rose to 36%.
A study of Fig. 1, 2 and 3 shows both
expected and unexpected findings. For
all cases (Fig. 1) the survivals are as
expected although the difference between
the mixed cellularity and lymphocytic
depletion groups is negligible at 5 years.
With patients with no systemic symptoms
the lymphocytic depletion group did
better than the mixed cellularity one.
Unexpectedly long survivals of patients
e-
m
3
-1
V)
with anaplastic tumours were noted in a
previous series reported from this hospital
(Lumb and Newton, 1957). For patients
with no systemic effects and only one
group of nodes involved (Fig. 3) the same
relationship was noted between the mixed
cellularity and lymphocytic depletion
groups, but unexpectedly, the nodular
sclerosis group did worst of all. As these
patients were not subjected to a diagnostic
laparotomy the staging does not take
fullv into account the possible presence
ofoccult disease below the diaphragm. As
1 2 3 4 5 Years
Fie. 1. Relation of survival to histologic type. All cases. Rye classification.
FIG. 2. Relation of survival to histological type for cases with no night sweats, pruritus or fever.
Rye classification.
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Lymphocytic Predominance
0 1 2 3 4 5 Years
Fic. 3.- Relation of survival to histological type for cases with no night sweats, pruritus or fever and only
one group of no(les involvedl. Rye classification.
the majority of nodular sclerosis Stage I
patients had disease in the cervical areas
only and not in the mediastinum, and
noting the converse relationship found by
Glatstein et al. (1970) between mediastinal
and abdominal disease, it may be that the
relatively poor survival in early stage
nodular sclerosis was due to undetected
para-aortic disease.
PART II-CLINICAL CONSIDERATIONS
These 250 cases were analysed with
the assistance ofthe Westminster Hospital
Medical Computer Centre. The relation-
ships between symptoms and survival, and
symptoms and histology were evaluated.
A study was also made of nodal involve-
ment and of the spread of the disease
from one group of nodes to another.
In this section only the Rye histological
classification is used. In some cases
documentation was inadequate in respect
of certain clinical details, an unfortunate
hazard of retrospective surveys. How-
ever, details of the disease process were
adequate and all the patients had been
followed for 5 years.
The staging criteria used in this study
were those of Rosenberg et al. (1971).
As this retrospective series contained no
extra nodal lymphomata and laparotomies
were not performed, the sub-staging used
for such cases in this classification has
been omitted from Table II.
TABLE IT. Clinical Classification
Stage Criteria
I Involvement of a single lymph node region.
II Involvement of two or more lymph node
regions on the same side ofthe diaphragm.
III . Involvement of lymph node regions on both
sides of the diaphragm which may be
accompanied by splenic involvement.
IV . Diffuse or disseminated involvement of one
or more extra lymphatic organs or tissues
with or without associated lymph node
enlargement.
The sub-staging of all patients with extra
lymphatic or splenic involvement initially
has not been used as this was not applic-
able to the series described.
All stages were sub-classified " A"
or " B " to indicate the absence or
presence respectively of systemic symp-
toms pruritus, night sweats or otherwise
unexpected fever. A single elevated
temperature reading was not thought
significant enough to classify the patient
in the " B " group. The staging of this
series is shown in Table III.
The present study attempts to evaluate
other symptoms not considered sufficient
in themselves to relegate a patient into the
" B " sub-group by this Committee.
Lymphangiography and mediastinaltomo-
graphy were not in use as diagnostic aids
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TABLE III.-
Stage
I A
I B
II A
II B
III A
III B
IV A
IV B
-Clinical Staging of Cases
Number of cases
111
.32
64
17
11
13
2
0
Total 250
30-
when the majority of these patients first
presented and the staging of the disease
may be inaccurate in this respect. This
probably explains the high number of
Stage I cases.
112
10 30 50 70
Age in Years
Fiom. 4. Distribution of series by age.
Survival time
Besides the actuarial method (IBerkson
and Gage, 1950) of expressing survival
rate, the mean and median survival times
are used. For these the survival time is
taken to be the time from onset of disease
to death, or to the time of the survey in
the case of live patients. The mean is the
average of the survival times, and the
median is the survival time of the patient
in the middle of the series when the
patients are arranged in order according
to survival time. The main advantage of
the median is that, provided it is less than
the 5-year follow-up period, it will remain
unaffected by patients who are still alive.
However, in a number of cases the median
is greater than 5 years so both mean and
median are used where appropriate.
Age and sex
The age incidence is shown in Fig. 4.
The peak incidence was the third decade
and the age range was 7-78 years. The
mean survival time decreased with age
(Fig. 5) except in the 70-80 year group
where there were only 3 patients. This
decrease was even more striking in the
male population (Fig. 6). These findings
are in agreement with Peters and Middle-
miss (1958) but at variance with Easson
(1966) who found that in males the
survival rate was not influenced by age.
Ficm. 5.-
10 70 68 70 ~E
E
Age in Years
R1elationship of mean survival to age.
10 30 50 70
FIG. 6. Relationship of mean suirvival to age
and sex.
Females over the age of 55 had a strikingly
poorer 5-year survival than women under
55. When compared with other series
(Johnson et al., 1970; Peters and Middle-
miss, 1958) there was an unusually high
preponderance of males (3 : 1). This can
be accounted for by the inclusion of
patients referred by the Armed Forces.
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Women of all age groups lived as long or
longer than men (Fig. 6). This may be
due to the fact that the nodular sclerosing
type of disease occurred in 44% of female
patients as against 27% of males. The
fact that no significant difference in
survival time could be found between the
sexes for any particular histological group
supports this view. The distribution of
males and females in the histological
sub-groups is shown in Table IV.
Influence of symptoms on survival
In addition to the classic trio of
night sweats, pruritus and fever, further
presenting clinical features were studied
to determine their influence on survival.
In assessing the different criteria listed in
Table V it should be made clear that there
are three categories: yes-denoting the
presence of the feature; no-denoting its
absence, and N.I.-when this factor was
not indicated in the notes.
The lack of precise information re-
garding certain signs and symptoms in an
appreciable number of cases is unfortu-
nate, but is an inherent problem in any
large retrospective survey.
It can be seen from Table V that
anorexia, feeling unwell, lassitude, night
sweats and weight loss reduced the
survival time. Other features which
significantly reduced survival were a
haemoglobin below 11-4 g %, a white cell
count above 15,000 per 'mm3 and a
temperature of 37.20 C or above. These
findings may be contrasted with those of
Fuller et al. (1971) who found no significant
reduction in survival time in patients
with constitutional symptoms. Features
which made no significant difference to
TABLE IV.-Relation Betwex
Lymphocytic No
predominance scl
Males . . 61
Females . 11
Total . . 72
% Males 32
% Females . 18
en
cdi
ler
5
2
7
2
4
survival were alcohol intolerance, cough
and dyspnoea. Pruritus, long accepted
as a criterion for Stage B disease, made
no significant difference to survival time
in this series when the cases were con-
sidered collectively regardless ofhistology.
This is in agreement with the new inter-
national classification. However, when
the histological sub-groups are considered
separately, the presence of pruritus in the
lymphocytic predominant group adversely
affected prognosis to a significant degree
(0.05 < P < 0-10) (Table VI).
Relation of symptoms to histology
The numbers in each individual group
are relatively small and it is difficult to
assess their statistical significance. The
findings are shown in Table VII and the
following comments may be made.
1. Feeling unwell and lassitude.-These
features were commonest in the lympho-
cytic depletion group.
2. Night sweats.-The highest percent-
age ofnight sweats occurred in the nodular
sclerosis group.
3. Pruritus.-This symptom was most
frequent in the nodular sclerosis group
(51%), and lowest with lymphocytic
depletion (23%).
4. Alcohol intolerance.-This was com-
monest in themixedcellularityvariety and
was not recorded at all with lymphocytic
depletion.
5. Cough.-This occurred most com-
monly with nodular sclerosis (35%).
This is in keeping with the predilection of
this histological variety for the media-
stinum.
6. Abnormal blood counts.-A haemo-
globin level less than 11-4 g % was found
i Sex and Histological Group
lular Mixed Lymphocytic
rosis cellularity depletion
1l . 49 . 30
'6 . 13 9
'7 62 39
7 26 15
4 . 22 16
The difference in distribution of histology between the sexes is significant (005 < P < 0.1).
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TABLE V.-Relationship ofSurvival Time to Signs, Symptoms and Simple Investigations
Sturvival in months
Yes
No
NI
Yes
No
NI
. Yes
No
NI
Yes
No
NI
Yes
No
NI
Yes
No
NI
Yes
No
NI
Yes
No
NI
erance Yes
No
NI
)0 Above
Below
NI
Above
Below
NI
37 2° C Above
Below
NI
Numbers
119
121
10
125
109
16
56
58
136
47
69
134
45
142
63
24
151
75
36
145
69
71
119
60
11
71
168
14
159
77
134
43
73
75
49
126
AMean Median
83
51
51
8:3
41
78
62
6:3
53
68
50
66
44
68
44
80
51
61
46
67
69
45
49
70
72
44
47
72
34
72
57
60
52
60
39
60
41
60
28
72
:34
60
47
60
60
34
,34
60
Level of sig. P
P < 0-001
P < 0-001
P < 0.005
NSD*
NSD*
-NSD*
0-025 < P < 0 05
P < 0-001
:NSD*
P < 0()1
P1 < 0.05
1' < 0-02.5
* No significant difference.
in 41 of patients with lymphocytic
depletion. A white blood count in excess
of 15,000 per mm3 was found in 130%
of nodular sclerosis cases and in 100% of
the lymphocytic depletion ones.
7. Fever.- A temperature of 37-2' C or
above on presentation was found in 82%
of the lymphocytic depletion cases. It
should be emphasized that the tempera-
ture figures refer to an isolated reading
on presentation and do not imply a
prolonged pyrexia or Pel-Epstein type
fever.
8. Splenomegaly.-The incidence of
splenomegaly was assessed (a) on pre-
sentation and (b) as a finding during the
progress of the disease. There was no
significant difference in the survival of
patients who developed a palpable spleen
during the course of the disease and those
with no splenomegaly. However, the
presence of splenomegaly on presentation
had a significant effect (P < 0.001) on
survival. Thus the median suirvival time
for 24 patients presenting with spleno-
megaly was 17 months, whereas for 226
patients with no splenomegaly on pre-
sentation it was 60 months.
When used as a guide to prognosis it
is interesting to note the differences in
Well
Lassitude
Night sweats
Pruritus
Cough
Dyspnoea
Anorexia
Weight loss
Alcohol intol(
W.B.C. 15,00
Hb. 11-4g
TemperatureHODGKIN S DISEASE 87
TABLE VI.-MedianSurvival Time (in Months) Related toSymptomsforEachHistological
Group
Lymphocytic Nodular Mixed Lymphocytic
Rye group predominance sclerosis cellularity depletion
Well . . . . Yes . 84 . 83 . 48 . 60
No . 44 56 38 26
Lassitude . . Yes . 44 . 56 . 38 . 26
No . 84 . 83 . 50 . 60
Night sweats. . Yes . 34 . 52 . 21 . 15
No . 72 . 78 . 55 . 39
Pruritus . . . Yes . 47 . 60 . 42 . 37
No 65 . 63 . 35 . 60
Cough. . . Yes . 60 . 61 . 26 . 29
No 72 . 60 . 50 . 38
Dyspnoea . . Yes . 60 . 60 . 27 . 19
No . 72 . 63 . 47 . 46
Anorexia . . Yes . 29 . 60 . 24 . 17
No . 72 . 65 . 35 . 38
Weight loss . . Yes . 28 . 55 . 25 . 17
No . 84 . . 48 . 54
Alcohol intolerance Yes . 8 . 34 . 67 . 0
No . 60 . 57 . 25 . 32
WBC > 15,000 . Yes . 66 . 34 . 49 . 17
No . 72 . 60 . 50 . 35
Hb. < 11.4 g. . . Yes . 72 . 45 . 16 . 24
No . 70 . 62 . 60 . 29
T° > 372°C. . . Yes . 60 . 44 . 27 . 17
No . 70 . 65 . 42 . 53
TABLE VII.-Numbers of Patients Grouped According to Rye Histology and Symptoms
and Simple Clinical Criteria
Lymphocytic Nodular Mixed Lymphocytic
predominance sclerosis cellularity depletion
Well . . . Yes 39 (57%) 34 (47%) . 32 (53%) . 14 (37%)
No . 30 . 39 28 24
Lassitude . . Yes . 32 (47%) . 41 (58%) . 28 (49%) . 24 (63%)
No . 36 30 . 29 . 14
Night sweats. . Yes 10 (30%) . 27 (61%) . 9 (47%) . 10 (53%)
No . 23 . 17 . 10 . 8
Pruritus . . . Yes . 13 (36%) 19 (51%) . 11 (42%) . 4 (23%)
No . 23 . 18 15 13
Cough . . . Yes . 9 (17%) . 20 (35%) . 9 (19%) . 7 (23%)
No . 44 . 38 . 37 . 23
Dyspnoea . . Yes . 5 (9-5%) . 8 (15%) 5 (12%) 6 (21%)
No 47 . 44 . 37 23
Anorexia . . . Yes . 5 (10%) . 13 (22%) . 9 (23%) . 9 (28%)
No . 44 . 47 . 31 23
Weight loss . . Yes . 13 (25%) . 27 (41%) . 16 (42%) 15 (45%)
No . 40 . 39 . 22 . 18
WBC > 15,000 . 2 (4%) . 7 (13%) * 2 (5%) . 3 (10%)
< 15,000 . . . 50 . 47 . 37 . 26
Hb. > 11-4g. . . 44 (84%) . 42 (75%) . 31 (76%) . 17 (59%)
< 11-4g. . . 8 . 14 . 10 12
Temperature > 37-2° C . . 15 (45%) . 25 (64%) . 17 (57%) . 18 (82%)
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survival found wi
absence of some of
symptoms. A tota
gave a mean and m
Rye groups as show
TABLE VIII. Mean
Times with Total
Histological type pa
Lymphocytic
predominance
Nodular sclerosis
Mixed cellularity
Lymphocytic
depletion
It is noteworthy thE
depletion group th
95 months signifyi
interpretation alon
guide to prognosis.
above that certain
importance prognost
toms in particular
TABLE IX. MJean
Times with Lassitud
Histological type pa
Lymphocytic
predominance
Nodular sclerosis
Mixed cellularity
Lymphocytic
depletion
aL)
C-)
0
.0
E
m
35
25 -
15-
5 -
/2
7-
5< 5<
th the presence or unwell and lassitude, there is a striking
the more significant similarity in the survival times irrespective
,1 lack of symptoms of histological groupings as shown in
Ledian survival in the Table IX.
,n in Table VIII. 9. Relapses.-The time interval be-
tween the first radiotherapy treatment
and Median Survival and a further manifestation of disease
Lack ofSymptoms was analysed. Of the initial 250 cases
Mean Median 67 (270%) did not relapse during the period
To. of survival survival of the study and remained disease free for
tients (months) (months) more than 5 years. Eighty-nine patients
23 112 125 (36%) died of their disease before any
13 96 84 further radiotherapy could be given.
12 58 39 This leaves 94 patients (380o) who had a
7 95 60 further manifestation of disease after
their first course of radiotherapy. The
at in the lymphocytic time interval to this recrudescence is
ie mean survival is illustrated in Fig. 7. It should be noted
ing that histological that 610% of patients who were to have a
e is an insufficient further manifestation of disease did so
It has been noted within 1 year and 980o within 5 years.
symptoms were of In keeping with the clinical finding of a
6ically. If two symp- variable rate of progression of disease in
are selected feeling different patients it was noted that in
those in whom the disease recrudesced
and Median Survival early (0-5 months after the first treat-
,e and Feeling Unwell ment) the median survival was only
Mean Median 46 months; in those where this took place
.Lo. of survival survival later (6-11 months) the median survival
ttients (months) (months) was 62 months.
16 67 60 Thirty-one per cent of the 250 total
11 . 56 55 cases had nodular sclerosing Hodgkin's
10 58 53 disease but 49%o of those that relapsed
7 . 57 . 29 had this histological variety suggesting
57/94 i.e. 61% of those going to relapse did so within one years
78 /94 i.e. 83% of those going to relapse did so within two years
87/94 i.e. 93% of those going to relapse did so within three years
92 /94 i.e. 98% of those going to relapse did so within five years
I I I
1 2 3 4
Interval to first recurrence
FIG. 7.
I 6
5 6 Years
- I_-- du C-.X
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that this group is more difficult to control
by radiotherapy. Patients who died
before a further manifestation of their
disease could be treated are excluded.
The percentage ofrelapses in the different
histological groups is shown in Table X.
TABLE X.-TheRelationship of Histological
Type to Relapses
Lymphocytic
predominance .
Nodular sclerosis
Mixed cellularity
Lymphocytic
depletion
Total no.
of cases Relapsed %
72
77
62
12
46
22
. 19
. 60
. 35
39 14 . 36
10. Spread of disease.-It has been
suggested that Hodgkin's disease spreads
in a largely predictable and orderly
manner from one lymph node group to
adjacent nodal areas (Rosenberg and
Kaplan, 1966). A study was made of our
250 patients to determine to what extent
the observed spread agreed with this
concept of orderly progression. It should
be remembered that the mediastinum and
para-aortic regions are relatively silent
areas where only gross disease will mani-
fest itself clinically. Lymphangiography
and mediastinal tomography were not
in regular use at the time these cases
presented.
An assessment was made of the most
likely transition from one nodal area to
another. For the purpose of this study
it was assumed that all involved nodes
resulted directly or indirectly from spread
from the original primary, and that
disease in a node detected on a certain
occasion could have spread from any other
involved nodal areawithequal probability.
Thus if n involved nodes were present
on an occasion the probability of disease
in a newly involved node having spread
from any other node is 1/n. These
" transition probabilities " were calcu-
lated for each patient according to the
nodes involved on various occasions during
the course of the disease. The " proba-
bilities" were then summed for all the
patients. The sums would contain terms
from transitions which do not occur but
it was hoped that the transitions which
occur most frequently would noticeably
increase the sum of the " transition
probabilities" for which they occur.
The " probability " of an involved
node in one section causing disease in
any other section was expressed as a
percentage of the total numbers of
transitions.
The most interesting and noticeable
transitions are illustrated in Table XI.
TABLE XI.-
Primary
Right neck
Left neck
Mediastinum
Right axilla
Left axilla
Para-aortics
Right groin
Left groin
Spread ofDisease
Secondary
Left neck
Mediastinum
Right axilla
Left axilla
Left axilla
Mediastinum
Right axilla
Left neck
Right neck
Left axilla
Right neck
Right axilla
Left neck
Left groin
Right groin
Left groin
Left axilla
Right groin
29
17
16
15
19
16
14
27
21
31
18
25
22
23
15
27
15
29
It may be significant that disease in
the axillae spreads to the mediastinum in
only 6% ofcases. This could be accounted
for by the late detection of disease in the
mediastinum. Mlediastinal disease, how-
ever, progressed both to the right axilla
(13%) and to the left axilla (12%). The
proportion of transitions between axillae
is higher than expected on anatomical
grounds and has been notedbyHutchinson
(1970). It is impossible to say whether or
not the mediastinum was involved en
route. We have not been able to confirm
the recent anatomical correlation between
the left side of neck and the para-aortic
nodes as the latter area being clinically
silent did not score highly in our investi-
gation.
89K. NEWTON, D. MACKENZIE, M. SPITTLE AND A. MIKOLAJCZUK
TREATMENT
All patients were treated initially by
irradiation. The treatment employed
during the period of this sttudy was
radiotherapy to the nodal areas involved.
The type of radiation used was either
60 Cobalt or 250 klV x-rays. The nodal
dose employed did not usually exceed
3500 rad in 3 5-4 weeks. Prophylactic
irradiation of the mediastinum advocated
by Peters and Middlemiss (1958) was
adopted towards the end of this series.
The mediastinum was irradiated when
disease presented in the neck or axilla
in the absence of mediastinal or hilar
disease. Sixty-sevein patients were treated
in this manner and, although no statistic-
ally significant difference could be found
uising the X2 test, there was a noticeable
difference in projected survival time
using the actuarial method, e.g. 69%o
5-vear survival with prophylactic media-
stinal irradiation as compared with 4900
surviving 5 years without this treatment
as shlown in Table XII.
TABLE XII. Survival Rates* for Patients
With and Without Prophylactic Radio-
therapy of the JMediastinum
Survival rate Survival rate
Suir-vival 'with without
time Ine(liastinal miediastinal
(years) irra(liation irra(diation
1 970o . 88%
2 88% . 740
5 690% 4900
7 570/^ : °,/,,8%
10 520(, :310/(
15 45°o 230
* Calculatecd by the actuarial method.
Extended field radiation or diagnostic
laparotomy and splenectomy as recently
advocated by Glatstein et al. (1970) were
not used at the time of this study and
lymphangiography and mediastinal tomo-
graphy were not in routine use.
No mention will be made during the
discussion of the effect of chemotherapy
on survival. This was employed mainly
for generalized disease (Stage IV) and
usuallv only single agents were used.
DISCUSSION
A reading ofthe literature ofHodgkin's
disease since the Rye classification came
into being reveals certain very disturbing
features. Firstly, there is the very wide
variation from series to series in the
incidence of nodular sclerosis mentioned
earlier. Secondly, the usefulness of any
classification must be decreased when a
team ofpathologists cannot agree amongst
themselves on a series of cases as indicated
by Keller et al. (1 l968). Thirdly, such
differences must account, in part at any
rate, for the very wide differences in
survival times in different series.
In the present series we found the
Rye classification moderately easy to use
although certain recuirring difficulties were
encountered. Problems connected with
poor quality histological sections have
already been mentioned. In a number of
cases we had difficulty in deciding whether
a case should be allocated to the lympho-
cytic predominance group or to mixed
cellularity. In others minimal collagen
and doubtfuil lacuna cells created difficulty
with the nodular sclerosing type.
Hitherto the major prognostic factors
in Hodgkin's disease have been clinical
staging and histology. Clinical staging
lays stress on the importance of the
diaphragm as an anatomical division
(Table II). Although differences in 5-year
survival figures have been detected in
these different clinical stages (Smithers,
1969), Cross and Dixon (1971) showed that
this anatomical consideration did not
have the same importance as symptoms
and histological grades. The survival
figures (54%o at 5 years) of our 250
patients seen between the years 1954 and
1966 are comparable with other series of
that time (Peters and Middlemiss, 1958;
Smithers, 1969).
Little attention has been given to
individual clinical features alone, or in
combination with histological grades. An
attempt has been made in this paper to
correlate these factors. We have been
able to demonstrate that pruritus has no
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prognostic value exceptin thelymphocytic
predominant cases. The important factors
are night sweats, anorexia, lassitude,
feeling unwell and weight loss. In
addition a high white blood count (above
15,000), a low Hb. (below 11P4 g) and
temperature recording on first attendance
of 37-2' C or above carried a poor prog-
nosis. Splenic enlargement on presenta-
tion also adversely affected prognosis.
These observations tend to show that
there are circumstances when the presence
or absence of certain symptoms are of
greater significance than histological grad-
ing. It is advocated that when an
attempt is made to assess the prognosis in
Hodgkin'sdisease, symptomatologyshould
always be correlated with histology if an
accurate guide to prognosis is sought.
We are indebted to our clinical
colleagues at Westminster Hospital, in the
Royal Army Medical Corps and in the
Royal Air Force for referring cases. We
acknowledge the secretarial help given by
Mrs M. Dixon, Mrs M. Taor and Mrs
A. Leaver. We thank the Department of
Medical Photography, Westminster
Hospital.
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